Frontlight ResearchEarly access
Gastric and oesophageal cancer trials in United States
273 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleA Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
- Where
- Aurora, Grand Rapids, Indianapolis, Sarasota, Seattle, Tucson
- Age
- 18 years and over
- People
- 260 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06663319 · EU 2024-516526-66-00 - Phase 2Taking peopleA Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma
- Where
- Fairway, Newark, New York, North Shores, Pittsburgh, Washington D.C.
- Age
- 18 years and over
- People
- 100 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07069712 · EU 2024-516909-23-00 - Phase 1Taking peopleA Phase 1 Study of IM-1617 in Participants With Advanced Cancer
- Where
- Boston, Houston, Irving, New Haven, Sarasota
- Age
- 18 years and over
- People
- 200
- Run by
- Immunome, Inc.
See details and how to joinNCT07578571 - Phase 1/2Taking peopleA Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
- Where
- Atlanta, Boston, Cleveland, Columbus, Dallas, Detroit, Fort Myers, Gainesville, Georgetown, Houston, Ithaca, La Jolla, Lone Tree, Los Angeles, Maumee, Memphis, Nashville, New York, Oklahoma City, Orlando, Philadelphia, Roanoke, Salt Lake City, San Diego, Spokane, St Louis, Syracuse, Tyler
- Age
- 18 years and over
- People
- 560 worldwide
- Run by
- Genmab
See details and how to joinNCT03526835 · EU 2024-513627-16-01 - Phase 4Taking peopleIntraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™)
- Where
- Los Angeles
- Age
- 18 years and over
- People
- 15
- Run by
- Cedars-Sinai Medical Center
See details and how to joinNCT07124351 - Phase 1/2Taking peopleCR-002 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
- Where
- Austin, Dallas, Fairfax
- Age
- 18 years and over
- People
- 219
- Run by
- Crescent Biopharma, Inc.
See details and how to joinNCT07909031 · EU 2026-527289-54-00 - Phase 1Taking peopleStudy of XB010 in Subjects With Solid Tumors
- Where
- Atlanta, Austin, Chicago, Dallas, Fairfax, Houston, Huntersville, Irvine, Los Angeles, Nashville, Oklahoma City, Orlando, St Louis, The Bronx, Washington D.C.
- Age
- 18 years and over
- People
- 396 worldwide
- Run by
- Exelixis
See details and how to joinNCT06545331 - Phase 1/2Taking peopleEIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
- Where
- Doral, Fort Worth, Hialeah, Houston, Lake Success, Los Angeles, Morristown, New York, Plantation, Tamarac
- Age
- 18 years and over
- People
- 160 worldwide
- Run by
- Eikon Therapeutics
See details and how to joinNCT07262619 · EU 2026-525248-13-00 - Phase 1Taking peopleA Study of MGC030 in Participants With Advanced Solid Tumors
- Where
- Lake Success
- Age
- 18 years and over
- People
- 314
- Run by
- MacroGenics
See details and how to joinNCT07822399 - No phaseTaking peopleObtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
- Where
- Bethesda
- Age
- 2 years and over
- People
- 1,800
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT01915225 - No phaseTaking peopleCancer Experience Registry (CER) for Cancer Patients and Caregivers
- Where
- Washington D.C.
- Age
- 18 years and over
- People
- 15,000
- Run by
- Cancer Support Community, Research and Training Institute, Philadelphia
See details and how to joinNCT02333604 - Phase 2Taking people18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
- Where
- Bethesda
- Age
- 18 years to 120 years
- People
- 320
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06503146 - Phase 1/2CompletedBOLD-100 in Combination With FOLFOX With or Without Bevacizumab for the Treatment of Advanced, Solid Tumours
- Where
- Santa Monica, Tampa
- Age
- 18 years and over
- People
- 220 worldwide
- Run by
- Bold Therapeutics, Inc.
See details and how to joinNCT04421820 · EU 2024-517500-11-00 - Phase 1Taking peopleKK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
- Where
- New Brunswick
- Age
- 18 years and over
- People
- 30
- Run by
- Christian Hinrichs
See details and how to joinNCT05483491 - Phase 1Taking peopleA Study of MGC026 in Participants With Advanced Solid Tumors
- Where
- Grand Rapids, Houston, Lake Success, Los Angeles, Portland, West Valley City
- Age
- 18 years and over
- People
- 394 worldwide
- Run by
- MacroGenics
See details and how to joinNCT06242470 - Phase 1/2Taking peopleLead-212 PSV359 Therapy for Patients With Solid Tumors
- Where
- Cleveland, Columbus, Dallas, Houston, Kansas City, Lexington, Los Angeles, Madison, Miami, New York, Omaha, Pittsburgh, Rochester, St Louis
- Age
- 18 years to 90 years
- People
- 112
- Run by
- Perspective Therapeutics
See details and how to joinNCT06710756 - Phase 1/2Taking peopleA Study to Investigate ALE.P02 as a Monotherapy or in Combination With Pembrolizumab in Adult Patients With Selected CLDN1+ Solid Tumors
- Where
- Chicago, Fairfax, Fullerton, Hackensack, Los Angeles, Louisville, New Haven, Scottsdale
- Age
- 18 years and over
- People
- 235 worldwide
- Run by
- Alentis Therapeutics AG
See details and how to joinNCT06747585 · EU 2024-515459-39-00 - Phase 1/2Taking peopleA Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
- Where
- Austin, Boston, Cleveland, Duarte, Fairfax, Houston, Huntersville, Irvine, Milwaukee, Nashville, Omaha, Orlando, Rochester, San Antonio, St Louis, West Valley City, Zion
- Age
- 18 years and over
- People
- 248 worldwide
- Run by
- Terremoto Biosciences Inc.
See details and how to joinNCT07109726 - No phaseNot yet taking people in United StatesALDH2 Genetic Testing in East Asian Community
- Where
- Chicago
- Age
- 18 years and over
- People
- 100
- Run by
- Northwestern University
See details and how to joinNCT07392775 - Phase 1/2Taking people[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
- Where
- Dallas, New York
- Age
- 18 years to 80 years
- People
- 71
- Run by
- Blue Earth Diagnostics
See details and how to joinNCT07432633 - Phase 1Taking peopleTesting the Combination of the Anticancer Drugs Trastuzumab Deruxtecan (DS-8201a) and Azenosertib (ZN-c3) in Patients With Stomach or Other Solid Tumors
- Where
- Houston
- Age
- 18 years and over
- People
- 48
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06364410 - Phase 1/2Taking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Amarillo, Chattanooga, Dallas, Fairfax, Germantown, Los Angeles, Minneapolis, Nashville, New York, Pearland, Salt Lake City, Skokie, Wenatchee, Westbury, White Plains, Whittier
- Age
- 18 years and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - Phase 3Taking peopleA Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)
- Where
- Brooklyn, Detroit, Fairfax, Fort Worth, Fullerton, Hershey, Kansas City, Los Angeles, Memphis, Morristown, Nashville, Orange, Phoenix, Rochester
- Age
- 18 years and over
- People
- 510 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06644781 · EU 2023-509630-19-00 - No phaseNot yet taking people in United StatesZanidatamab Outcomes and Lived Experiences in Advanced HER2+ GEA
- Where
- Houston, Orange
- Age
- 18 years and over
- People
- 300
- Run by
- Jazz Pharmaceuticals
See details and how to joinNCT07780968 - Phase 1Taking peoplePhase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic
- Where
- Boston, Fairfax, Irving, Lubbock, Oklahoma City, Orlando
- Age
- 18 years and over
- People
- 285
- Run by
- Sutro Biopharma, Inc.
See details and how to joinNCT07807345